The Trial of Parkinson’s and Zoledronic acid (TOPAZ) is seeking to enroll 3,500 participants over the age of 60, making it the largest double-blind, placebo-controlled, randomized clinical trial ever attempted in people with parkinsonism. Find out the approaches taken and the results in this case study.
|